MED-CANN

BY MED-TECH WORLD

Innovation across the whole of healthcare

The cannabis industry is one that has traditionally been fraught with regulatory hurdles, gray areas and ethical pot holes. It is refreshing to finally reap the results of long discussions and negotiations between all those involved and see this industry flourish across countries, as more and more countries lift their restrictions and new businesses move into play.

From seed-to-sale tracking to personal, patient-based medical products, the convergence of these two spheres promises great things for the future of medical cannabis, something we’re sure many of the investors attending our summits will be keen to explore.

This same shift is also alluring for the hope it brings to patients suffering from chronic illnesses, something which we have been very keen to explore in our past editions. Patients too deserve to have their thoughts heards and wishes served.

SiGMA, being a pioneer in the Medical-Cannabis Conference Industry was very adamant to continue hosting this vertical, in parallel with Malta’s perseverance to build its own flourishing Medical Cannabis Industry and as a result, will continue to host this during the Malta Week two-day summit, with a separate stage solely dedicated to medical cannabis and other related topics, including the rise of psychedelics.

Showcase your company!
Apply now for the chance to win 10-minutes on stage in front of an opportunity hungry crowd who will be seeking their next investment or partnership.

Partners

Richard Skaife

Over the last few years we have witnessed what is in many cases ancient medicine step back into the spotlight. Psychedelic Medicine has moved from the underground and taboo to being centre stage at events such as Davos and Concordia. Clinical trials progress at pace across the world with some new therapies being expected to be approved as early as 2023 in the United States. Progressive and conservative jurisdictions all have major unmet medical needs around mental health, addiction & trauma and psychedelic medicine continues to show incredible promise. Ketamine therapy can be accessed legally in several hundred locations in the United States with Europe playing a catch up. Malta is set to be home to one of the biggest centres of care & excellence.

LILAC MANDELES

Med Cann is a meeting point for global leaders in all areas of Medical Cannabis; industry managers, influential scientists, clinicians, entrepreneurs, investors, policymakers, and thought leaders gather for the ultimate opportunity to make an impact in this field. I believe that accessing knowledge and global networks is essential in understanding the way forward within the complex ecosystem of the medical cannabis industry.

STEPHEN OLIVER

Having supported the Med-Tech event since 2019 both Matt Lawson and I regard this as the premier European conference and a World leader. The support at Government level and the outstanding organisation by SIGMA set the event apart.

Medicinal Cannabis and Med-Tech are at the forefront of patient access, professional adoption and delivery mechanism development. We view the conference as the opportunity to meet and discuss industry issues with medical professionals, government ministers, leaders in the field of medical technology and a global network of friends. This is an event that is first in the calendar and we urge those in the industry to attend.

Jacky Ong

CISW Summit was first held in 2020, a grand-scale virtual summit that brings together a team of leading cannabis experts, scientists, university professors, researchers, entrepreneurs, investors, and developers from Thailand and around the world. Partnering up with Med-Cann World Summit by SiGMA was the next most logical thing to do. We look forward to connecting Thailand with the rest of the world through the upcoming Malta November Med-Cann Summit, as we seek to continue developing the medical cannabis industry in Asia and beyond.

3rd CISW SUMMIT WORLD joining MED-CANN SUMMIT!

Cannabis Investment Summit World (CISW) is currently one of the biggest cannabis and hemp events in Asia.Led by Mr. Jacky Ong, President of CISW Holding Group, CISW will showcase how Thailand is proving to be one of the world’s emerging medical cannabis hubs.

Gathering an audience from all over the world for everyone who is interested in all aspects of the medical cannabis and hemp industry, including research and development, investment opportunities, and the science behind therapeutics. The summit aims to be a timely and informative conference. Our dedicated team aims to attract leaders and investors from both public and private sectors around the world.

Main Sponsors; 88 Cannatek

https://www.ciswinternational.com/cisw-summit

Thursday 17th November 2022 (Med-Cann World)

10:00-13:00

Spinola Stage

10:00-10:40

A patient focussed presentation of Medicinal Cannabis as a treatment for paediatric epilepsy patients in the U.K. with special attention to the collation of clinical evidence

MATTHEW LAWSON

Co-Founder at The Canna Consultants

STEPHEN OLIVER

Co-founder at The Canna Consultants

10:40-11:20

Challenges for the Medical Cannabis Industry in Europe

LILAC MANDELES

Founder/CEO at TechforCann & Board Director of Meuhedet HMO

Narkis Tessler

Chief Strategy Officer at Medocann Pharma Ltd.

MARION ZAMMIT

Chief Officer Investment Promotion at Malta Enterprise

Angele Azzopardi de Berniere

Chief Executive Officer at ZenPharm Limited

Peter Paul Farrugia

Plant Director at A2W Pharma

11:20-11:40

Keynote by Assi Rotbart

Assi Rotbart

General Manager at Panaxia Pharmaceutical Industries Ltd

11:40-12:05

Calibrating the Entourage Effect; Precision dosing and the future of medicine

Jean Claude Scicluna

Principal Scientist & Medical Director at Cellotex & Founder of The Plant Medicine Clinics

12:05-12:25

THC & CBD used via an inhalation device. Where are we at?

Jekaterina Parovincaka

Regulatory Affairs Associate at Tetra Bio-Pharma Europe Ltd.

12:25-12:50

Developing a cannabinoid-based formulation for the treatment of cancer

Prof. Hinanit Koltai, PhD

Senior Research Scientist and the Director of Academic Affairs at the Agricultural Research Organization, Volcani Center, Israel

Friday 18th November 2022 (Med-Cann World)

10:00-17:00

Spinola Stage Day 2

10:45-10:55

Start-up Showcase : Syms SARL

Timo Nurminen

Founder & CEO at Smys SARL

10:55-11:05

Start-up Showcase : TRUSTT

Mike Sikorski

CEO / Co-Founder at TRUSTT

11:05-11:40

Medical Cannabis at the intersection of biotech, pharma and big data - Building a winning portfolio in the emerging medical cannabis field

LILAC MANDELES

Founder/CEO at TechforCann & Board Director of Meuhedet HMO

11:40-11:55

Export and Import through the European Union.

Narkis Tessler

Chief Strategy Officer at Medocann Pharma Ltd.

11:55-12:15

Understanding the Complexity of the Endocannabinoid system as base of Medicinal Cannabis Treatment

Professor Giuseppe Di Giovanni

Professor of Human Physiology and Neuroscience at the University of Malta

12:15-12:35

Investing in Psychedelic Medicine

Henri Sant-Cassia

Partner at The Conscious Fund, COO at Longr and Advisor to The Psychedelic Medicine Association and The Hive